AU Stock MarketDetailed Quotes
AGN Argenica Therapeutics Ltd
- 0.770
- -0.015-1.91%
20min DelayMarket Closed Nov 1 16:00 AET
98.63MMarket Cap-14528P/E (Static)
0.825High0.755Low254.07KVolume0.755Open0.785Pre Close200.36KTurnover0.98552wk High0.28%Turnover Ratio128.09MShares0.32552wk Low-0.053EPS TTM70.48MFloat Cap1.020Historical HighLossP/E (Static)91.53MShs Float0.250Historical Low-0.053EPS LYR8.92%Amplitude--Dividend TTM7.06P/B1Lot Size--Div YieldTTM
About Argenica Therapeutics Ltd Company
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.
Company Profile
SymbolAGN
Company NameArgenica Therapeutics Ltd
Founded2019
MarketASX
Fiscal Year Ends06-30
Address117 Broadway Unit 4
CityNedlands
CountryAustralia
Zip Code6009
Phone+61 893293396
Websitehttps://www.argenica.com.au
Share RegistryLINK MARKET SERVICES LIMITED
Level 12 QV1 Building, 250 St Georges Terrace, PERTH, WA, AUSTRALIA, 6000
1300 554 474
Company Executives
- Name
- Position
- Salary
- Liz Dallimore
- Chief Executive Officer,Managing Director
- --
- Terrence (Terry) Charles Budge
- Non-Executive Director
- --
- Elizabeth (Liddy) McCall
- Non-Executive Director
- --
- Dianne Margaret Angus
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data